Reveal Pharmaceuticals

Reveal Pharmaceuticals is a small biotechnology company based in Cambridge, Massachusetts, with a team of four employees. Founded with the mission of transforming medical insight and improving human health, Reveal is focused on developing innovative solutions for the medical imaging industry. Reveal Pharmaceuticals specializes in the development of contrast agents for magnetic resonance imaging (MRI). Their patented contrast agents utilize manganese, an essential mineral for life, as a safe and sustainable alternative to traditional gadolinium-based agents. Reveal’s lead product, RVP-001, is currently in the IND-ready stage and aims to directly replace existing MRI contrast agents, offering a significant benefit to both patients and the environment. Reveal’s innovative approach to MRI contrast agents addresses a critical issue: the accumulation of gadolinium, a heavy metal, in the bodies of patients following traditional MRI scans. This buildup contributes to rising levels of gadolinium in surface waters, raising environmental concerns. Reveal’s manganese-based contrast agents offer a solution that is both safe for human health and environmentally friendly. For more information about Reveal Pharmaceuticals and their groundbreaking work in medical imaging, please visit their website at revealpharma.com.